耿巍,傅向华,田祥,刘轶园,刘倩梅,孟海云,刘欣,李亭亭,李良,王培军

• 1:河北省保定市第一中心医院心内科
• 2:河北医科大学第二医院心内科

摘要(Abstract)：

目的本研究旨在评价瑞替普酶溶栓成功后12 h内经桡动脉行经皮冠状动脉介入治疗(PCI)对急性ST段抬高心肌梗死(STEMI)患者的安全性及可行性。方法 224例急性STEMI患者,应用瑞替普酶溶栓治疗,溶栓成功后随机分为早期介入治疗(E-PCI)组和择期介入治疗(S-PCI)组(各112例)。E-PCI组于分组后12 h内经桡动脉行PCI,S-PCI组于分组后1周经桡动脉行PCI。主要终点为住院期间复合终点事件的发生率,包括死亡、再发心肌梗死、再发心绞痛与充血性心力衰竭;次要终点为12个月随访期内的死亡、再发心肌梗死、再发心绞痛与再次血运重建的发生率。结果两组患者的基线资料差异无统计学意义。E-PCI组住院时间较S-PCI组明显缩短(P<0.001)。E-PCI组与S-PCI组术后冠状动脉TIMI血流分布、无复流的发生率、梗死相关血管分布及对比剂用量方面差异无统计学意义,但E-PCI组患者应用替罗非班的比例明显偏高(30.3%比10.7%,P=0.001)。E-PCI组主要终点事件发生率明显降低(4.5%比14.3%,P=0.022),两组住院期间再发心肌梗死、充血性心力衰竭及死亡等指标差异无统计学意义,在12个月随访期内累计的死亡、再发心肌梗死及再发心绞痛差异无统计学意义。两组根据TIMI分级标准记录到的出血并发症的发生率差异无统计学意义。结论急性STEMI患者,如不能及时行直接PCI,则应用瑞替普酶溶栓后早期经桡动脉行PCI可明显降低患者住院期间再发心绞痛的发生率。

关键词(KeyWords)： 瑞替普酶;经皮冠状动脉介入治疗;支架;心肌梗死

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 耿巍,傅向华,田祥,刘轶园,刘倩梅,孟海云,刘欣,李亭亭,李良,王培军

参考文献(References)：

• [1]Simes RJ,Topol EJ,Holmes DR Jr,et al.Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion.Importance of early and complete infarct artery reperfusion.GUSTO-I Investigators.Circulation,1995,91:1923-1928.
• [2]Ross AM,Coyne KS,Moreyra E,et al.Extended mortality benefit of early postinfarction reperfusion.GUSTO-I Angiographic Investigators.Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial.Circulation,1998,97:1549-1556.
• [3]Keeley EC,Boura JA,Grines CL.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials.Lancet,2003,361:13-20.
• [4]Andersen HR,Nielsen TT,Rasmussen K,et al.A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.N Engl J Med,2003,349:733-742.
• [5]The GUSTO Angiographic Investigators.The effects of tissue plasminogen activator,streptokinase,or both on coronary-artery patency,ventricular function,and survival after acute myocardial infarction.N Engl J Med,1993,329:1615-1622.
• [6]Hudson MP,Granger CB,Topol EJ,et al.Early reinfarction after fibrinolysis:experience from the global utilization of streptokinase and tissue plasminogen activator(alteplase)for occluded coronary arteries(GUSTO I)and global use of strategies to open occluded coronary arteries(GUSTO III)trials.Circulation,2001,104:1229-1235.
• [7]Pilote L,Miller DP,Califf RM,et al.Recurrent ischemia after thrombolysis for acute myocardial infarction.Am Heart J,2001,141:559-565.
• [8]陈书中,左国兴,王宽.延迟冠状动脉介入治疗与静脉溶栓后药物保守治疗的对比研究.中国介入心脏病学杂志,2004,12:147-150.
• [9]Ellis SG,Tendera M,de Belder MA,et al.Facilitated PCI in patients with ST-elevation myocardial infarction.N Engl J Med,2008,358:2205-2217.
• [10]Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention(ASSENT-4PCI)investigators.Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction(ASSENT-4 PCI):randomised trial.Lancet,2006,367:569-578.
• [11]韩立宪,王贵松,徐泽升,等.急性心肌梗死急诊介入治疗与静脉溶栓后急诊介入治疗的比较研究.中国介入心脏病学杂志,2002,10:209-210.
• [12]Di Mario C,Dudek D,Piscione F,et al.Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction(CARESS-in-AMI):an open,prospective,randomised,multicentre trial.Lancet,2008,371:559-568.
• [13]Cantor WJ,Brunet F,Ziegler CP,et al.Immediate angioplasty after thrombolysis:a systematic review.CMAJ,2005,173:1473-1481.
• [14]Simoons ML,Arnold AE,Betriu A,et al.Thrombolysis with tissue plasminogen activator in acute myocardial infarction:no additional benefit from immediate percutaneous coronary angioplasty.Lancet,1988,1:197-203.
• [15]Arnold AE,Serruys PW,Rutsch W,et al.Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction:a regional wall motion analysis.European Cooperative Study Group.J Am Coll Cardiol,1991,17:11-21.
• [16]Schmig A,Kastrati A,Mudra H,et al.Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure.Circulation,1994,90:2716-24.
• [17]Scheller B,Hennen B,Hammer B,et al.Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction.J Am Coll Cardiol,2003,42:634-641.
• [18]Le May MR,Wells GA,Labinaz M,et al.Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction(CAPITAL AMI study).J Am Coll Cardiol,2005,46:417-424.
• [19]Cantor WJ,Burnstein J,Choi R,et al.Transfer for urgent percutaneous coronary intervention early after thrombolysis for STelevation myocardial infarction:the TRANSFER-AMI pilot feasibility study.Can J Cardiol,2006,22:1121-1126.
• [20]Cantor WJ,Fitchett D,Borgundvaag B,et al.Routine early angioplasty after fibrinolysis for acute myocardial infarction.N Engl J Med,2009,360:2705-2718.
• [21]Bhmer E,Hoffmann P,Abdelnoor M,et al.Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI(NORwegian study on DIstrict treatment of ST-elevation myocardial infarction).J Am Coll Cardiol,2010,55:102-110.
• [22]Fernandez-Avilés F,Alonso JJ,Castro-Beiras A,et al.Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation(GRACIA-1):a randomised controlled trial.Lancet,2004,364:1045-1053.
• [23]Armstrong PW.A comparison of pharmacologic therapy with/without timely coronary intervention vs.primary percutaneous intervention early after ST-elevation myocardial infarction:the WEST(Which Early ST-elevation myocardial infarction Therapy)study.Eur Heart J,2006,27:1530-1538.
• [24]万方,张拓,何奔,等.急性ST段抬高心肌梗死溶栓后早期介入治疗与直接介入治疗的对比研究.中国介入心脏病学杂志,2013,21:3-7.
• [25]Thiele H,Engelmann L,Elsner K,et al.Comparison of prehospital combination-fibrinolysis plus conventional care with prehospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.Eur Heart J,2005,26:1956-1963.
• [26]Jang JS,Jin HY,Seo JS,et al.The transradial versus the transfemoral approach for primary percutaneous coronary intervention in patients with acute myocardial infarction:a systematic review and meta-analysis.EuroIntervention,2012,8:501-510.